|
Designated Public Office Holders who participated in the communication:
|
Judith Seidman,
Senator
Senate of Canada
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Health,
Research and Development
|
Communications regarding access to and approval of medicines addressing the growing public health threat of antimicrobial resistance.
|
|
Federal-Provincial Relations,
Health
|
Communications regarding national pharmacare legislation, regulations, policies or programs.
|
|
Health
|
Communications regarding the value assessment of new medicines by Canada's Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors.
|
|
| |
|
Responsible Officer who filed this communication report:
|
RAMI FAYED
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
